Boza P - Search Results

1

CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients.

Krall P, Yañez D, Rojo A, Delucchi Á, Córdova M, Morales J, Boza P, de la Rivera A, Espinoza N, Armijo N, Castañeda LE, Farfán MJ, Salas C. Krall P, et al. Among authors: boza p. Front Pharmacol. 2021 Apr 22;12:653525. doi: 10.3389/fphar.2021.653525. eCollection 2021. Front Pharmacol. 2021. PMID: 33967795 Free PMC article.

2

Evaluation of limited-sampling strategies to calculate AUC_(0-24) and the role of CYP3A5 in Chilean pediatric kidney recipients using extended-release tacrolimus.

Galvez C, Boza P, González M, Hormazabal C, Encina M, Azócar M, Castañeda LE, Rojo A, Ceballos ML, Krall P. Galvez C, et al. Among authors: boza p. Front Pharmacol. 2023 Mar 14;14:1044050. doi: 10.3389/fphar.2023.1044050. eCollection 2023. Front Pharmacol. 2023. PMID: 36998611 Free PMC article.

3

IFN-β Plays Both Pro- and Anti-inflammatory Roles in the Rat Cardiac Fibroblast Through Differential STAT Protein Activation.

Bolívar S, Anfossi R, Humeres C, Vivar R, Boza P, Muñoz C, Pardo-Jimenez V, Olivares-Silva F, Díaz-Araya G. Bolívar S, et al. Among authors: boza p. Front Pharmacol. 2018 Nov 28;9:1368. doi: 10.3389/fphar.2018.01368. eCollection 2018. Front Pharmacol. 2018. PMID: 30555324 Free PMC article.

4

Differential regulation of collagen secretion by kinin receptors in cardiac fibroblast and myofibroblast.

Catalán M, Smolic C, Contreras A, Ayala P, Olmedo I, Copaja M, Boza P, Vivar R, Avalos Y, Lavandero S, Velarde V, Díaz-Araya G. Catalán M, et al. Among authors: boza p. Toxicol Appl Pharmacol. 2012 Jun 15;261(3):300-8. doi: 10.1016/j.taap.2012.04.013. Epub 2012 Apr 18. Toxicol Appl Pharmacol. 2012. PMID: 22554775

5

Cardiac fibroblast death by ischemia/reperfusion is partially inhibited by IGF-1 through both PI3K/Akt and MEK-ERK pathways.

Vivar R, Humeres C, Varela M, Ayala P, Guzmán N, Olmedo I, Catalán M, Boza P, Muñoz C, Díaz Araya G. Vivar R, et al. Among authors: boza p. Exp Mol Pathol. 2012 Aug;93(1):1-7. doi: 10.1016/j.yexmp.2012.01.010. Epub 2012 Apr 17. Exp Mol Pathol. 2012. PMID: 22537549

6

Cardiac fibroblasts as sentinel cells in cardiac tissue: Receptors, signaling pathways and cellular functions.

Díaz-Araya G, Vivar R, Humeres C, Boza P, Bolivar S, Muñoz C. Díaz-Araya G, et al. Among authors: boza p. Pharmacol Res. 2015 Nov;101:30-40. doi: 10.1016/j.phrs.2015.07.001. Epub 2015 Jul 4. Pharmacol Res. 2015. PMID: 26151416 Review.

7

FoxO1 mediates TGF-beta1-dependent cardiac myofibroblast differentiation.

Vivar R, Humeres C, Muñoz C, Boza P, Bolivar S, Tapia F, Lavandero S, Chiong M, Diaz-Araya G. Vivar R, et al. Among authors: boza p. Biochim Biophys Acta. 2016 Jan;1863(1):128-38. doi: 10.1016/j.bbamcr.2015.10.019. Epub 2015 Oct 28. Biochim Biophys Acta. 2016. PMID: 26518453 Free article.

8

Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1β synthesis, secretion, and degradation.

Boza P, Ayala P, Vivar R, Humeres C, Cáceres FT, Muñoz C, García L, Hermoso MA, Díaz-Araya G. Boza P, et al. Mol Immunol. 2016 Jun;74:96-105. doi: 10.1016/j.molimm.2016.05.001. Epub 2016 May 9. Mol Immunol. 2016. PMID: 27174187

9

Cardiac fibroblast cytokine profiles induced by proinflammatory or profibrotic stimuli promote monocyte recruitment and modulate macrophage M1/M2 balance in vitro.

Humeres C, Vivar R, Boza P, Muñoz C, Bolivar S, Anfossi R, Osorio JM, Olivares-Silva F, García L, Díaz-Araya G. Humeres C, et al. Among authors: boza p. J Mol Cell Cardiol. 2016 Oct 27:S0022-2828(16)30392-3. doi: 10.1016/j.yjmcc.2016.10.014. Online ahead of print. J Mol Cell Cardiol. 2016. PMID: 27983968

10

Lipopolysaccharide Activates Toll-Like Receptor 4 and Prevents Cardiac Fibroblast-to-Myofibroblast Differentiation.

Bolívar S, Santana R, Ayala P, Landaeta R, Boza P, Humeres C, Vivar R, Muñoz C, Pardo V, Fernandez S, Anfossi R, Diaz-Araya G. Bolívar S, et al. Among authors: boza p. Cardiovasc Toxicol. 2017 Oct;17(4):458-470. doi: 10.1007/s12012-017-9404-4. Cardiovasc Toxicol. 2017. PMID: 28220374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page